WAM
AVNS

Wallington Asset Management’s Avanos Medical AVNS Stock Holding History

Wallington Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,449
Closed -$238K – 69
2021
Q1 		$238K Sell
5,449
-800
-13% -$37.5K 0.04% 65
2020
Q4 		$287K Sell
6,249
-275
-4% -$11.4K 0.06% 56
2020
Q3 		$217K Buy
+6,524
New +$208K 0.05% 55
2020
Q1 		– Sell
-6,962
Closed -$235K – 50
2019
Q4 		$235K Sell
6,962
-270
-4% -$9.78K 0.05% 59
2019
Q3 		$271K Sell
7,232
-96
-1% -$3.66K 0.07% 52
2019
Q2 		$320K Sell
7,328
-86
-1% -$3.68K 0.08% 48
2019
Q1 		$316K Sell
7,414
-76
-1% -$3.4K 0.08% 48
2018
Q4 		$335K Sell
7,490
-44
-0.6% -$2.31K 0.1% 46
2018
Q3 		$516K Sell
7,534
-86
-1% -$5.53K 0.12% 47
2018
Q2 		$436K Sell
7,620
-112
-1% -$5.92K 0.11% 47
2018
Q1 		$356K Sell
7,732
-164
-2% -$7.79K 0.09% 51
2017
Q4 		$365K Sell
7,896
-178
-2% -$8.18K 0.09% 52
2017
Q3 		$364K Sell
8,074
-307
-4% -$13.1K 0.1% 52
2017
Q2 		$329K Sell
8,381
-131
-2% -$4.95K 0.09% 54
2017
Q1 		$324K Sell
8,512
-34
-0.4% -$1.32K 0.09% 58
2016
Q4 		$316K Sell
8,546
-189
-2% -$6.75K 0.1% 56
2016
Q3 		$303K Sell
8,735
-159
-2% -$5.57K 0.1% 55
2016
Q2 		$289K Sell
8,894
-7
-0.1% -$214 0.09% 58
2016
Q1 		$256K Sell
8,901
-33
-0.4% -$879 0.08% 58
2015
Q4 		$298K Sell
8,934
-48
-0.5% -$1.49K 0.1% 58
2015
Q3 		$255K Sell
8,982
-25
-0.3% -$872 0.09% 57
2015
Q2 		$365K Hold
9,007
– – 0.12% 53
2015
Q1 		$443K Buy
9,007
+63
+0.7% +$2.92K 0.14% 51
2014
Q4 		$407K Buy
+8,944
New +$351K 0.13% 55

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Wallington Asset Management's AVNS Position: Q2 2021 in Review

Wallington Asset Management sold out of Avanos Medical (AVNS) in Q2 2021, closing a stake of 5,449 shares — an estimated $238K sold.

Wallington Asset Management first reported a position in AVNS in Q4 2014 and held it in 24 quarters. The position peaked at $516K in Q3 2018. 274 funds tracked by Wall St. Rank hold AVNS as of Q2 2021.

  • Wallington Asset Management reported no remaining Avanos Medical position as of Q2 2021 after selling out during the quarter.
  • Wallington Asset Management sold 5,449 Avanos Medical shares in Q2 2021, an estimated $238K.
  • Wallington Asset Management first reported a position in Avanos Medical in Q4 2014 and held it in 24 quarters.
  • Wallington Asset Management's Avanos Medical position peaked at $516K in Q3 2018.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2021.

Based on Wallington Asset Management's 13F filing for Q2 2021, filed 16 Jul 2021.